Financial Performance - The company's revenue for Q1 2025 was ¥304,877,987.78, a decrease of 3.44% compared to ¥315,727,870.21 in the same period last year[4] - Net profit attributable to shareholders was ¥23,123,042.02, down 11.75% from ¥26,200,443.33 year-on-year[4] - Basic earnings per share decreased to ¥0.0800, down 11.70% from ¥0.0906 in the same period last year[4] - Total operating revenue decreased to CNY 304,877,987.78 from CNY 315,727,870.21, representing a decline of approximately 3.7% year-over-year[21] - Net profit for the period was CNY 24,303,774.57, down from CNY 27,150,657.98, reflecting a decrease of approximately 10.8% year-over-year[22] - The company's weighted average return on equity was 1.67%, a decrease of 0.31% compared to 1.98% in the previous year[4] - The company reported a comprehensive income total of CNY 50,986,275.16, compared to CNY 10,766,830.69 in the previous period, indicating a significant increase[22] Cash Flow - The net cash flow from operating activities was -¥48,356,259.60, a significant decline of 2,340.21% compared to -¥1,981,641.03 in the previous year[4] - Operating cash inflow totaled $304,395,539.51, an increase from $293,625,779.41 in the previous period[24] - Operating cash outflow amounted to $352,751,799.11, compared to $295,607,420.44 last period, resulting in a net cash flow from operating activities of -$48,356,259.60[24] - Investment cash inflow was $60,381,319.22, down from $85,212,438.09 in the prior period, while investment cash outflow reached $62,262,921.04, leading to a net cash flow from investing activities of -$1,881,601.82[24] - Financing cash inflow increased to $73,000,000.00 from $14,800,000.00, with financing cash outflow at $50,465,654.90, resulting in a net cash flow from financing activities of $22,534,345.10[25] - The net increase in cash and cash equivalents was -$24,842,390.67, compared to -$40,641,706.37 last period[25] - The ending balance of cash and cash equivalents stood at $328,334,023.44, up from $253,894,274.56 in the previous period[25] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,990,268,597.61, an increase of 3.50% from ¥1,922,886,539.75 at the end of the previous year[4] - Total liabilities rose to CNY 550,905,951.12 from CNY 534,510,168.42, an increase of approximately 3.1%[19] - The company's equity attributable to shareholders increased to CNY 1,392,827,227.10 from CNY 1,343,022,884.46, reflecting a growth of about 3.7%[19] - The company's goodwill increased to CNY 485,979,927.24 from CNY 470,270,017.59, an increase of about 3.3%[19] - Long-term borrowings rose to CNY 200,131,000.00 from CNY 166,651,000.00, an increase of approximately 20.0%[19] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 21,105[10] - The company received government subsidies amounting to ¥758,774.40 during the reporting period, which positively impacted its financial performance[5] - The company has established a professional legal team to address ongoing litigation related to equity payment disputes, ensuring the protection of shareholder rights[15] Strategic Initiatives - The company successfully held a global agricultural cost-reduction and yield-increase technology seminar in March 2025, launching the "Agricultural Doctor" green agriculture brand[14] - The company was recognized as one of the "Top 100 High-tech Enterprises in Hubei Province," enhancing its reputation in innovation and technology[15] - The company plans to change its stock abbreviation to "Fubon Technology" starting January 2, 2025, to better reflect its strategic focus on technological innovation[13] - The company is committed to driving agricultural cost reduction and yield increase through technological innovation and sustainable development strategies[14] - The company aims to deepen its strategic layout in agricultural chemical additives and specialty fertilizers, promoting resource allocation and R&D collaboration[13] Current Assets - The company reported a total current assets of CNY 955,559,576.94 as of March 31, 2025, an increase from CNY 898,195,927.71 at the beginning of the period, representing a growth of approximately 6.7%[17] - Accounts receivable increased to CNY 289,294,451.35 from CNY 236,481,071.65, reflecting a rise of about 22.2%[17] - Inventory levels rose to CNY 199,530,272.51, up from CNY 176,828,870.45, indicating an increase of approximately 12.8%[17] Operating Costs - Total operating costs decreased to CNY 273,936,249.03 from CNY 278,152,630.61, a reduction of about 1.6% year-over-year[21] - Cash received from sales of goods and services was $300,565,753.87, compared to $290,125,971.98 previously[24] - Cash paid for goods and services was $273,961,207.67, an increase from $225,458,423.58 in the prior period[24] - Employee compensation payments totaled $33,319,176.29, up from $27,083,378.06 last period[24]
富邦股份(300387) - 2025 Q1 - 季度财报